US M&A and equity raisings
3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds
Deals dated after 30 September 2026 are still being collected.
8 deals · US$2.3bndisclosed · Clinical Trial Services · Clear
Columns
| Date | Target | Vendor | Acquirer | Type | Status | Value US$m | Sector | Advisers |
|---|---|---|---|---|---|---|---|---|
| Jan 2026 | SubjectWell | – | – | Merger | Announced | – | Clinical Trial Services | Stout (sell-side)Fairmount Partners (buy-side) |
| Apr 2026 | Celerion | H.I.G. Capital affiliate | THL Partners | Acquisition | Announced | – | Pharma Services+2 | LazardKirkland & Ellis (buy-side)Paul, Weiss (buy-side) |
| Apr 2026 | EpiVax | – | SV Health Investors | Acquisition | Announced | – | Pharma Services+2 | Morgan Lewis (buy-side) |
| Aug 2026 | ZEPHYRx | – | a Leading Global CRO | Acquisition | Completed | – | Healthcare Software+1 | Morgan Lewis (sell-side)Edgemont Partners (sell-side) |
| Aug 2026 | Precision Medicine Group | Blackstone | McKesson | Acquisition | Announced | 2,250.0 | Clinical Trial Services+1 | Debevoise & Plimpton (sell-side)Centerview Partners (sell-side)Davis Polk (buy-side) |
| Sep 2026 | New Zealand Clinical Research Group (NZCR) | – | Advent | Acquisition | Announced | – | Clinical Trial Services | Cameron Partners (buy-side) |
| Sep 2026 | Firma Data Services | Firma Clinical Research | Everest Clinical Research | Asset sale | Completed | – | Clinical Trial Services+1 | Edgemont Partners (sell-side) |
| Sep 2026 | MLM Medical Labs | – | Labcorp | Acquisition | Announced | – | Clinical Trial Services+1 | William BlairEvercore (buy-side)Pierson Ferdinand (buy-side)Hogan Lovells Cadwalader (buy-side) |
Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built